NCT01374620 2026-03-16
PAL-ANGI2
Centre Oscar Lambret
Phase 1 Completed
Clinical Trials
17 trialsNCT07046936 2026-03-03
MITO-RES
Wake Forest University Health Sciences
Recruiting
NCT01915797 2026-02-13
TED
Assistance Publique - Hôpitaux de Paris
Completed
NCT00349830 2026-02-10
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University
Recruiting
NCT06826066 2026-01-15
TRANSPROUST
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT07284589 2025-12-16
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT03922893 2025-12-15
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
Memorial Sloan Kettering Cancer Center
Recruiting
NCT07178847 2025-12-01
NeckTAR-IN
Centre Jean Perrin
Phase NA Recruiting
NCT06962995 2025-10-24
Multi-Cancer Detection Observational Cohort Study
Mayo Clinic
Recruiting
NCT06782451 2025-09-29
DST
Centre Antoine Lacassagne
Phase NA Recruiting
NCT02751827 2025-08-24
PreToxE
Institut Bergonié
Completed
NCT03996239 2025-07-17
Researching the Effect of Aerobic Exercise on Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT06287749 2025-07-10
French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
University Hospital, Montpellier
Recruiting
NCT03984318 2025-06-26
PREMIS
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Active not recruiting
NCT06956391 2025-06-04
Ultralow Dose PET Imaging of 18F-FDG Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
NCT05324553 2025-05-02
Patient Derived Preclinical Models
Mayo Clinic
Recruiting